metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Analysis of biofilm production and expression of adhesion structures of circulat...
Journal Information
Vol. 40. Issue 8.
Pages 445-448 (October 2022)
Share
Share
Download PDF
More article options
Visits
693
Vol. 40. Issue 8.
Pages 445-448 (October 2022)
Brief report
Full text access
Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico
Análisis de la producción de biopelícula y expresión de estructuras de adhesión de cepas circulantes de Clostridioides difficile en México
Visits
693
Adrián Martínez-Meléndeza, Rayo Morfin-Oterob, Licet Villarreal-Treviñoc, Simon D. Bainesd, Adrián Camacho-Ortíze, Elvira Garza-Gonzáleze,
Corresponding author
elvira_garza_gzz@yahoo.com

Corresponding author.
a Universidad Autónoma de Nuevo León, Facultad de Ciencias Químicas, Pedro de Alba S/N, Ciudad Universitaria, San Nicolás de los Garza, Nuevo Leon, Mexico
b Hospital Civil de Guadalajara “Fray Antonio Alcalde” e Instituto de Patología Infecciosa y Experimental, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
c Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, Pedro de Alba S/N, Ciudad Universitaria, San Nicolás de los Garza, Nuevo Leon, Mexico
d University of Hertfordshire, School of Life and Medical Sciences, Department of Clinical, Pharmaceutical, and Biological Sciences, Hatfield, UK
e Universidad Autónoma de Nuevo León, Hospital Universitario “Dr. José Eleuterio González”, Monterrey, N.L., Mexico
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Introduction

Clostridioides difficile biofilms are believed to protect the pathogen from antibiotics, in addition to potentially contributing to recurrent infections.

Methodology

Biofilm production of 102 C. difficile isolates was determined using the crystal violet staining technique, and detachment assays were performed. The expression levels of cwp84 and slpA genes were evaluated by real-time PCR on selected isolates.

Results

More than 70% of isolates (75/102) were strong biofilm producers, and the highest detachment of biofilm was achieved with the proteinase K treatment (>90%). The overall mean expression of cwp84 was higher in RT027 than in RT001 (p=0.003); among strong biofilm-producing strains, the slpA expression was lower in RT027 than in RT001 (p<0.000).

Conclusions

Proteins seem to have an important role in the biofilm's initial adherence and maturation. slpA and cwp84 are differentially expressed by C. difficile ribotype and biofilm production level.

Keywords:
Clostridioides difficile
Biofilm
Ribotype 027
Ribotype 001
Cwp84
slpa
Resumen
Introducción

Se cree que las biopelículas de Clostridioides difficile (C. difficile) protegen al patógeno de los antibióticos, además de contribuir potencialmente a las infecciones recurrentes.

Metodología

Se determinó la producción de biopelículas de 102 aislados de C. difficile, mediante la técnica de tinción con violeta cristal y se realizaron ensayos de desprendimiento. Los niveles de expresión de los genes cwp84 y slpA se evaluaron mediante PCR en tiempo real en aislados seleccionados.

Resultados

Más del 70% de los aislados (75/102) fueron fuertes productores de biopelículas y el mayor desprendimiento de biopelícula se logró con el tratamiento con proteinasa K (> 90%). La expresión media global de cwp84 fue mayor en RT027 que en RT001 (p = 0,003); entre las cepas productoras fuertes de biopelícula, la expresión de slpA fue menor en RT027 que en RT001 (p < 0,000).

Conclusiones

Las proteínas parecen tener un papel importante en la adhesión y maduración inicial de las biopelículas; slpA y cwp84 se expresan de forma diferente según el ribotipo de C. difficile y el nivel de producción de biopelículas.

Palabras clave:
Clostridioides difficile
Biopelícula
Ribotipo 027
Ribotipo 001
cwp84
slpA
Full Text
Introduction

Clostridioides difficile is a Gram-positive, strictly anaerobic, spore-producing bacterium, and it is the most common infectious cause of nosocomial diarrhoea.1 While C. difficile spores are essential for the transmission and persistence of C. difficile infection, other factors such as intestinal colonization and the formation of bacterial communities in the intestine can also contribute to the pathogenesis and persistence of the disease. Nevertheless, these factors have not been extensively investigated.2

For several pathogens, the ability to form biofilms has been associated with recurrent infections.3 The biofilm matrix protects bacteria by providing a closed environment and generally consists of an extracellular polymeric substance, which can comprise proteins, DNA, and polysaccharides.4 The biofilm matrix can act as an initial physical barrier that prevents the penetration of antimicrobial agents; other attributes such as the bacteria's physiological state can also contribute to drug resistance.4

The surface-layer protein A (SlpA, encoded by slpA) is a precursor involved in adhesion and is cleaved by the cell wall cysteine protease (Cwp84, encoded by cwp84), to form the high and low molecular weight subunits in the S-layer of C. difficile.2 Exposure to subinhibitory concentrations of ampicillin and clindamycin increases the expression of genes encoding colonization factors, such as Cwp66, P47, Fbp68, and Cwp84.5

The aim of the present study was to analyze biofilm production and the expression of genes that encode proteins involved in the biofilm production of circulating C. difficile strains from Mexico.

MethodsIsolates and evaluation of biofilm production

In this study, 102 strains with previously characterized ribotypes were included.6 Strains were obtained from patients with a confirmed C. difficile infection diagnosis from two Mexican tertiary-care hospitals; only one isolate per patient was included (Table 1).

Table 1.

Ribotypes of C. difficile strains classified by biofilm production.

Classification  n (%)  Ribotype (n
Nonproducer  22 (21.6)  027 (15), 001 (7) 
Weak producer  5 (4.9)  027 (4), 001 (1) 
Strong producer  75 (73.5)  027 (63), 001 (12) 

The evaluation of biofilm production was determined by crystal violet staining using the conditions described by Dawson et al.7 with the following modifications: 96-well microplates (Corning Inc, NY, USA) were used and the biofilm was incubated for 48h at 37°C in anaerobiosis. After incubation, absorbance at 595nm (planktonic cells) was measured, and an additional fixing/drying step was performed for one hour at 60°C. The biofilm was stained with 0.1% Hucker's crystal violet, and the stain was dissolved with 30% acetic acid for 30min. The experiments were performed per triplicate for each isolate. The biofilm index (BI) was calculated,8 and isolates were classified as nonproducer (BI<0.9), weak producer (BI, 0.9–1.2), or strong producer (BI>1.2).

Detachment assays

Detachment assays were performed on selected isolates as previously described.8 Isolates were classified as demonstrating no detachment (<10%), intermediate detachment (10–50%), moderate detachment (51–75%), or strong detachment (>75%).

Evaluation of the expression of genes associated with adherence

The expression levels of genes slpA and cwp84 were evaluated by real-time PCR. Total RNA was extracted using the QIAmp DSP viral RNA mini kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. Standard curves were constructed for the target genes (slpA and cwp84) and the endogenous gene (16S rRNA). Oligonucleotides and PCR conditions reported by Deneve et al. were used.5 The results obtained for each isolate and gene were normalized using the expression levels of the strain C. difficile ATCC 9689. Overexpression was defined by relative expression that increased 300% compared with the calibrator strain.

Statistical analysis

The associations of each ribotype with levels of biofilm production as well as the results of the detachment assays were determined by the chi-square test; the Mann–Whitney test was used to determine differences in the results of the expression assays. For both analyses, the SPSS Statistics version 22.0 software (IBM Corporation, Somers, NY) was used, and a P value less than 0.05 was considered to be statistically significant.

ResultsBiofilm production and detachment assays

More than 70% (75/102) of the isolates were classified as strong biofilm producers, most of which were RT027 (Table 1). No association was found between the ribotypes and strong biofilm production (p>0.05). Biofilm detachment assays were performed in 72 strong biofilm-producing strains: 12 RT001 isolates and 60 RT027 isolates. Detachment percentages higher than 90% were obtained for both ribotypes with proteinase K treatment. When NaIO4 was used for treatment, approximately 60% of the isolates in both ribotypes had intermediate and moderate detachment. When DNase I was used, approximately 50% of the isolates had a strong detachment in RT027; a similar proportion was found in RT001 but with intermediate detachment (Table 2).

Table 2.

Detachment assay results by C. difficile ribotype and relative expression of cwp84 and slpA.

Ribotype  001 (n=12)  027 (n=60)  p 
Proteinase K
Strong detachment, n (%)  12 (100)  60 (100)  n/a 
NaIO4
No detachment, n (%)  2 (16.7)  5 (8.3)   
Intermediate, n (%)  4 (33.3)  21 (35)   
Moderate, n (%)  4 (33.3)  18 (30)   
Strong, n (%)  2 (16.7)  16 (26.7)  0.722 
Dnase I
No detachment, n (%)  0 (0)  0 (0)   
Intermediate, n (%)  7 (58.3)  10 (16.7)   
Moderate, n (%)  2 (16.7)  16 (26.7)   
Strong detachment, n (%)  3 (25)  34 (56.7)  0.089 
Expression assays (mean expression±SD)
  n  001  n  027  p 
cwp84
All isolates  17  0.47±0.45  27  1.28±0.88  0.003 
Nonproducers  0.56±0.48  13  1.6±0.97  0.049 
Strong producers  12  0.43±0.46  14  0.99±0.68  0.105 
slpA
All isolates  17  2.45±1.42  27  2.16±4.45  0.795 
Nonproducers  2.73±1.3  13  3.7±0.51  0.237 
Strong producers  12  2.34±1.51  14  0.77±1.65  0.000 

SD, standard deviation; n/a, not applicable.

Expression of cwp84 and slpA

Forty-four selected isolates were included for cwp84 and slpA expression assays: 17 RT001 isolates (5 nonproducers and 12 strong producers) and 27 RT027 isolates (13 nonproducers and 14 strong producers).

The overall mean expression of cwp84 was significantly higher in RT027 than in RT001, regardless of biofilm production classification (p=0.003). Similar results were found in non-biofilm-producing strains (p=0.049). By contrast, among strong-producing strains, the mean slpA expression was significantly lower in RT027 than in RT001 (p<0.000) (Table 2).

Discussion

For C. difficile, biofilm represents a closed environment that protects the bacterial population from the pressure of antibiotics, but it can also promote the recurrence of the disease.2 In this study, we analyzed the biofilm production and expression of genes related to the adhesion of circulating C. difficile strains from Mexico.

Most of the analyzed isolates were strong biofilm producers, regardless of the ribotype. RT027 isolates were more likely to be strong biofilm producers (63/82, 76.8%), with no statistical significance detected. Similarly, the analysis of biofilm production in 37 strains showed no correlation between the ability to form a biofilm and the ribotype.9

In the present study, the participation of proteins, carbohydrates, and extracellular DNA as components of the matrix was evaluated. Previous studies have shown that proteins are incorporated into the matrix during the maturation of biofilm and are required for the assembly of the biofilm.10 In our study, all strains showed detachment higher than 90% when the 48-h biofilm is treated with proteinase K, reinforcing the important role of proteins in the initial adherence and/or the biofilm maturation process.

Subinhibitory concentrations of metronidazole have been reported to increase the biofilm production of C. difficile strains.11 A thick biofilm characterized by layered aggregates has been demonstrated by confocal laser scanning microscopy (CLSM) imaging. The CLSM provided evidence for the binding of concanavalin A to exopolysaccharide (EPS) residues of matrix.11 In our study, carbohydrate contribution to the extracellular matrix was variable, suggesting differences in the type of carbohydrate and their proportions.

Extracellular DNA (eDNA) has also been described as an essential component of C. difficile biofilm, but in lower proportions than proteins.12 It has been suggested that eDNA in the biofilm matrix results from phage-mediated bacterial cell lysis and other unknown eDNA release mechanisms.13 In previous studies, the staining pattern of the DOC-induced biofilm with BOBO-3 and SYPRO Ruby Red showed a net-like structure that implicates eDNA and proteins in the biofilm matrix. The presence of eDNA in the DOC-induced biofilm matrix was demonstrated on an agarose gel, and treatment with DNase dispersed previously formed biofilm.10 Our results suggest that DNA plays an essential role in the biofilm of RT027, considering the detachment rates in this ribotype.

In the present work, we evaluated the expression of slpA and cwp84 genes in biofilm; however, we found low expression of these genes. The low expression observed may be explained by the model used because the expression was not induced by stressing the cells (either by antibiotic or other conditions), which may have promoted the adherence and formation of biofilm.5 Similarly, the ligands for these adhesins are present on host tissue but not in polystyrene plates; thus, increased expression of these adhesins may depend on the presence of the ligands.14 Also, these genes may not be expressed at high levels once a biofilm is established.14

A limitation of our study was the use of one species biofilm because in vivo biofilms are multispecies and complex. It has been demonstrated that C. difficile aggregates with Fusobacterium nucleatum; together, these species produce mature biofilms by means of the Fusobacterium protein RadD.15 Therefore, attachment and stability mechanisms may differ from in vitro studies, and key species may be needed to establish biofilms and facilitate attachment and survival. Another limitation is the proportion of isolates per included ribotype. The strains were recovered from patients of two tertiary hospitals from 2011 to 2016. However, in 2014, there was an outbreak due to the RT027 strain in one of the hospitals, which may have generated ribotype proportion bias.

In conclusion, most C. difficile clinical isolates were strong biofilm producers. Proteins may have an essential role in the initial adherence and maturation of the biofilm matrix and the contribution of DNA and carbohydrates was variable, suggesting a complex mechanism of biofilm production. The low levels of expression of genes associated with adherence, highlights the need to find suitable models for the study of the C. difficile biofilm to understand its role in the pathogenesis.

Funding sources

This work received no specific grant from any funding agency.

Conflict of interest

The author(s) declare that there are no conflicts of interest.

Acknowledgments

The authors thank Lucy Acevedo for technical support.

References
[1]
J. Czepiel, M. Drozdz, H. Pituch, E.J. Kuijper, W. Perucki, A. Mielimonka, et al.
Clostridium difficile infection: review.
Eur J Clin Microbiol Infect Dis, 38 (2019), pp. 1211-1221
[2]
C. Vuotto, G. Donelli, A. Buckley, C. Chilton.
Clostridium difficile biofilm.
Adv Exp Med Biol, 1050 (2018), pp. 97-115
[3]
S. Hathroubi, M.A. Mekni, P. Domenico, D. Nguyen, M. Jacques.
Biofilms: microbial shelters against antibiotics.
Microb Drug Resist, 23 (2017), pp. 147-156
[4]
S.H. Jung, C.M. Ryu, J.S. Kim.
Bacterial persistence: fundamentals and clinical importance.
J Microbiol, 57 (2019), pp. 829-835
[5]
C. Deneve, C. Delomenie, M.C. Barc, A. Collignon, C. Janoir.
Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression.
J Med Microbiol, 57 (2008), pp. 732-738
[6]
A. Martinez-Melendez, L. Tijerina-Rodriguez, R. Morfin-Otero, A. Camacho-Ortiz, L. Villarreal-Trevino, H. Sanchez-Alanis, et al.
Circulation of highly drug-resistant Clostridium difficile ribotypes 027 and 001 in two tertiary-care hospitals in Mexico.
Microb Drug Resist, 24 (2018), pp. 386-392
[7]
L.F. Dawson, E. Valiente, A. Faulds-Pain, E.H. Donahue, B.W. Wren.
Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.
[8]
S. Mendoza-Olazaran, R. Morfin-Otero, L. Villarreal-Trevino, E. Rodriguez-Noriega, J. Llaca-Diaz, A. Camacho-Ortiz, et al.
Antibiotic susceptibility of biofilm cells and molecular characterisation of Staphylococcus hominis isolates from blood.
PLOS ONE, 10 (2015), pp. e0144684
[9]
V. Pantaleon, M. Monot, C. Eckert, S. Hoys, A. Collignon, C. Janoir, et al.
Clostridium difficile forms variable biofilms on abiotic surface.
[10]
T. Dubois, Y.D.N. Tremblay, A. Hamiot, I. Martin-Verstraete, J. Deschamps, M. Monot, et al.
A microbiota-generated bile salt induces biofilm formation in Clostridium difficile.
NPJ Biofilms Microbiomes, 5 (2019), pp. 14
[11]
C. Vuotto, I. Moura, F. Barbanti, G. Donelli, P. Spigaglia.
Subinhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains.
Pathog Dis, 74 (2016), pp. fvt14
[12]
T. Ethapa, R. Leuzzi, Y.K. Ng, S.T. Baban, R. Adamo, S.A. Kuehne, et al.
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.
J Bacteriol, 195 (2013), pp. 545-555
[13]
R.T. Slater, L.R. Frost, S.E. Jossi, A.D. Millard, M. Unnikrishnan.
Clostridioides difficile LuxS mediates inter-bacterial interactions within biofilms.
[14]
G.A. Maldarelli, K.H. Piepenbrink, A.J. Scott, J.A. Freiberg, Y. Song, Y. Achermann, et al.
pili promote early biofilm formation by Clostridium difficile.
Pathog Dis, 74 (2016), pp. ftw061
[15]
M. Engevik, H.A. Danhof, J. Auchtung, B.T. Endres, W. Ruan, E. Basseres, et al.
Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus.
Copyright © 2021. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos